Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet‐induced obese and biopsy‐confirmed mouse model of NASH

• Main Authors: Mathias B. Møllerhøj (Author), Sanne S. Veidal (Author), Kirstine Tølbøl Thrane (Author), Denise Oró (Author), Agnete Overgaard (Author), Casper Gravesen Salinas (Author), Martin Rønn Madsen (Author), Larissa Pfisterer (Author), Mogens Vyberg (Author), Eric Simon (Author), Andre Broermann (Author), Niels Vrang (Author), Jacob Jelsing (Author), Michael Feigh (Author), Henrik H. Hansen (Author)
• Format: Book
• Published: Wiley, 2022-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Non‐alcoholic steatohepatitis (NASH) has emerged as a major challenge for public health because of high global prevalence and lack of evidence‐based therapies. Most animal models of NASH lack sufficient validation regarding disease progression and pharmacological treatment. The Gubra‐Amylin...